119 studies found for:    Open Studies | "Diabetic Retinopathy"
Show Display Options
Rank Status Study
21 Unknown  Macular Tractional Retinoschisis in Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention:
22 Recruiting Genetic Markers and Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention: Genetic: genetic analysis
23 Not yet recruiting Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention: Drug: Aflibercept
24 Recruiting 25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: Ranibizumab;   Drug: Triamcinolone Acetonide
25 Recruiting Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: Intravitreal dexamethasone implant;   Procedure: Vitrectomy
26 Recruiting Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: emixustat hydrochloride;   Other: Placebo
27 Recruiting Intravitreal Injection of Ranibizumab Versus Sham Before Vitrectomy in Patients With Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: ranibizumab;   Drug: sham;   Procedure: pars plana vitrectomy
28 Recruiting Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy
Condition: Non-proliferative Diabetic Retinopathy
Interventions: Drug: Compound danshen dripping pills;   Drug: Placebo
29 Recruiting Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
Condition: Nonproliferative Diabetic Retinopathy
Interventions: Drug: Intravitreal aflibercept injection [IAI];   Drug: Sham
30 Recruiting A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy
Condition: Non-Proliferative Diabetic Retinopathy
Interventions: Drug: 1.0mg Luminate®;   Drug: 2.0mg Luminate®;   Drug: 3.0mg Luminate®;   Other: Balanced Salt Solution for intravitreal injection in 0.10cc
31 Recruiting Comparison of Interval Variation and Dosage in Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy
Condition: Proliferative Diabetic Retinopathy, Pars Plana Vitrectomy, Intravitreal Bevacizumab
Intervention: Drug: Intravitreal bevacizumab
32 Recruiting The Effect of Hyperbaric Chamber Treatment on Patients With Diabetic Retinopathy
Condition: Does Hyperbaric Chaber Treatment Improve Diabetic Retinopathy
Intervention:
33 Unknown  Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy
Conditions: Non Proliferative Diabetic Retinopathy;   Proliferative Diabetic Retinopathy
Interventions: Drug: Folic Acid, vit B6 and B12;   Drug: Placebo
34 Unknown  Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study
Conditions: Uveitis;   Diabetic Retinopathy;   Choroidal Neovascularization
Intervention: Drug: adalimumab
35 Unknown  A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
Condition: Diabetic Retinopathy
Intervention: Drug: Vitreosolve
36 Unknown  Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)
Condition: Diabetic Retinopathy
Intervention: Drug: bevacizumab
37 Unknown  The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention: Drug: Triamcinolone
38 Unknown  Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage
Conditions: Diabetic Retinopathy;   Vitreous Hemorrhage
Intervention: Drug: intravitreal ranibizumab injections
39 Recruiting Anti-VEGF Treatment for Prevention of PDR/DME
Conditions: Diabetic Retinopathy;   Diabetic Macular Edema
Interventions: Procedure: Prompt Sham;   Drug: Prompt aflibercept;   Procedure: Deferred laser;   Drug: Deferred aflibercept
40 Unknown  Safety and Efficacy of Low-Fluence PRP for PDR
Condition: Proliferative Diabetic Retinopathy
Interventions: Device: Low-fluence PRP with 532nm green LASER;   Device: Full-Fluence PRP with 532nm LASER

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years